ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs English Health Press Release ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs April 29, 2021 ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical...Read More
